期刊
FRONTIERS IN CHEMISTRY
卷 7, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fchem.2019.00472
关键词
Alzheimer's disease; dementia; neurodegenerative disorders; difficult peptide sequences; amyloid beta; peptide chemistry; solid phase peptide synthesis
资金
- Maurice Wilkins Centre for Molecular Biodiscovery
Aggregation of the pathological amyloid beta (A beta) isoform A beta(1-42) into senile plaques is a neuropathological hallmark of Alzheimer's disease (AD). The biochemical significance of this phenomenon therefore necessitates the need for ready access to A beta(1-42) for research purposes. Chemical synthesis of the peptide, however, is technically difficult to perform given its propensity to aggregate both on resin during solid phase peptide synthesis and in solution during characterization. This review presents a chronological summary of key publications in the field of A beta(1-42) synthesis, dating back from its maiden synthesis by Burdick et al. Challenges associated with the preparation of A beta(1-42) were identified, and the solutions designed over the course of time critically discussed herein. Ultimately, the intention of this review is to provide readers with an insight into the progress that has been made in the last three decades, and how this has advanced broader research in AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据